Crystal structure demonstrates binding competition of factor VIIa with protein C in hemophilia, suggesting implications for rFVIIa treatment.
During the past few decades, numerous studies provided evidence for a productive interaction between activated factor VII (FVIIa) and the endothelial protein C receptor (EPCR). However, a structure that settles the docking orientation and binding signature was still lacking. We report here the crystal structure of factor VII Gla domain bound to human EPCR, revealing a binding geometry in essence indistinguishable from that of the PC-EPCR interface. FVII Gla locks onto EPCR surface through the cooperative contribution of Ca2+ ions, residues of gamma carboxyglutamic acid and the hydrophobic omega-loop, essentially recapitulating PC docking, and confirming absolute structural competition for EPCR binding. These findings resolve a long-standing gap and inform the structural basis for the binding of a pharmacologically relevant coagulation factor to EPCR, illustrating the complete steric competition with PC. Such competition is dictated by a conserved Gla domain fold-driven mechanism of recognition with potential implications for pharmacological rFVIIa intervention in hemophilia.
No takes yet. Share an insight, caveat, or question.
López‐Sagaseta et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: